The missing puzzle piece: Splicing mutations

International Journal of Clinical and Experimental Pathology

Volumn 6, Issue 12, 2013, Pages 2675-2682

  Lewandowska, Marzena A ^a,b  

^a Regional Oncology Centre Bydgoszcz   (Poland)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

Author keywords

aberrant splicing; Branch point; Molecular pathology; Mutations

Indexed keywords

ABERRANT SPLICING; ANIMAL; BRANCH POINT; EXON; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HUMAN; INTRON; METHODOLOGY; MOLECULAR PATHOLOGY; MUTATION; MUTATIONS; NUCLEOTIDE SEQUENCE; REVIEW; RNA SPLICING;

ABERRANT SPLICING; BRANCH POINT; MOLECULAR PATHOLOGY; MUTATIONS;

ANIMALS; DNA MUTATIONAL ANALYSIS; EXONS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INTRONS; MUTATION; RNA SPLICE SITES; RNA SPLICING;

EID: 84888783419     PISSN: None     EISSN: 19362625     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Venter JC, Adams MD, Myers EW, Li PW, Mural RJ, Sutton GG, Smith HO, Yandell M, Evans CA, Holt RA, Gocayne JD, Amanatides P, Ballew RM, Huson DH, Wortman JR, Zhang Q, Kodira CD, Zheng XH, Chen L, Skupski M, Subramanian G, Thomas PD, Zhang J, Gabor Miklos GL, Nelson C, Broder S, Clark AG, Nadeau J, McKusick VA, Zinder N, Levine AJ, Roberts RJ, Simon M, Slayman C, Hunkapiller M, Bolanos R, Delcher A, Dew I, Fasulo D, Flanigan M, Florea L, Halpern A, Hannenhalli S, Kravitz S, Levy S, Mobarry C, Reinert K, Remington K, Abu-Threideh J, Beasley E, Biddick K, Bonazzi V, Brandon R, Cargill M, Chandramouliswaran I, Charlab R, Chaturvedi K, Deng Z, Di Francesco V, Dunn P, Eilbeck K, Evangelista C, Gabrielian AE, Gan W, Ge W, Gong F, Gu Z, Guan P, Heiman TJ, Higgins ME, Ji RR, Ke Z, Ketchum KA, Lai Z, Lei Y, Li Z, Li J, Liang Y, Lin X, Lu F, Merkulov GV, Milshina N, Moore HM, Naik AK, Narayan VA, Neelam B, Nusskern D, Rusch DB, Salzberg S, Shao W, Shue B, Sun J, Wang Z, Wang A, Wang X, Wang J, Wei M, Wides R, Xiao C, Yan C, Yao A, Ye J, Zhan M, Zhang W, Zhang H, Zhao Q, Zheng L, Zhong F, Zhong W, Zhu S, Zhao S, Gilbert D, Baumhueter S, Spier G, Carter C, Cravchik A, Woodage T, Ali F, An H, Awe A, Baldwin D, Baden H, Barnstead M, Barrow I, Beeson K, Busam D, Carver A, Center A, Cheng ML, Curry L, Danaher S, Davenport L, Desilets R, Dietz S, Dodson K, Doup L, Ferriera S, Garg N, Gluecksmann A, Hart B, Haynes J, Haynes C, Heiner C, Hladun S, Hostin D, Houck J, Howland T, Ibegwam C, Johnson J, Kalush F, Kline L, Koduru S, Love A, Mann F, May D, McCawley S, McIntosh T, McMullen I, Moy M, Moy L, Murphy B, Nelson K, Pfannkoch C, Pratts E, Puri V, Qureshi H, Reardon M, Rodriguez R, Rogers YH, Romblad D, Ruhfel B, Scott R, Sitter C, Smallwood M, Stewart E, Strong R, Suh E, Thomas R, Tint NN, Tse S, Vech C, Wang G, Wetter J, Williams S, Williams M, Windsor S, Winn-Deen E, Wolfe K, Zaveri J, Zaveri K, Abril JF, Guigo R, Campbell MJ, Sjolander KV, Karlak B, Kejariwal A, Mi H, Lazareva B, Hatton T, Narechania A, Diemer K, Muruganujan A, Guo N, Sato S, Bafna V, Istrail S, Lippert R, Schwartz R, Walenz B, Yooseph S, Allen D, Basu A, Baxendale J, Blick L, Caminha M, Carnes-Stine J, Caulk P, Chiang YH, Coyne M, Dahlke C, Mays A, Dombroski M, Donnelly M, Ely D, Esparham S, Fosler C, Gire H, Glanowski S, Glasser K, Glodek A, Gorokhov M, Graham K, Gropman B, Harris M, Heil J, Henderson S, Hoover J, Jennings D, Jordan C, Jordan J, Kasha J, Kagan L, Kraft C, Levitsky A, Lewis M, Liu X, Lopez J, Ma D, Majoros W, McDaniel J, Murphy S, Newman M, Nguyen T, Nguyen N, Nodell M, Pan S, Peck J, Peterson M, Rowe W, Sanders R, Scott J, Simpson M, Smith T, Sprague A, Stockwell T, Turner R, Venter E, Wang M, Wen M, Wu D, Wu M, Xia A, Zandieh A and Zhu X. The sequence of the human genome. Science 2001; 291: 1304-1351
2. Patel AA and Steitz JA. Splicing double: insights from the second spliceosome. Nature reviews. Mol Cell Biol 2003; 4: 960-970.
3. Maroney PA, Romfo CM and Nilsen TW. Functional recognition of 5' splice site by U4/U6.U5 tri-snRNP defines a novel ATP-dependent step in early spliceosome assembly. Mol Cell 2000; 6: 317-328.
4. Valadkhan S and Manley JL. Splicing-related catalysis by protein-free snRNAs. Nature 2001; 413: 701-707.
5. Sanford JR and Caceres JF. Pre-mRNA splicing: life at the centre of the central dogma. J Cell Sci 2004; 117: 6261-6263.
6. Reed R. The organization of 3' splice-site sequences in mammalian introns. Genes Dev 1989; 3: 2113-2123.
7. Zhu J and Krainer AR. Pre-mRNA splicing in the absence of an SR protein RS domain. Genes Dev 2000; 14: 3166-3178.
8. Roscigno RF and Garcia-Blanco MA. SR proteins escort the U4/U6.U5 tri-snRNP to the spliceosome. RNA 1995; 1: 692-706.
9. Blencowe BJ. Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases. Trends Biochem Sci 2000; 25: 106-110.
10. Anastasiadou C, Malousi A, Maglaveras N and Kouidou S. Human epigenome data reveal increased CpG methylation in alternatively spliced sites and putative exonic splicing enhancers. DNA Cell Biol 2011; 30: 267-275.
11. Buratti E, Chivers M, Hwang G and Vorechovsky I. DBASS3 and DBASS5: databases of aberrant 3'- and 5'-splice sites. Nucleic Acids Res 2011; 39: D86-91.
12. Cartegni L, Wang J, Zhu Z, Zhang MQ and Krainer AR. ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res 2003; 31: 3568-3571.
13. Highsmith WE, Burch LH, Zhou Z, Olsen JC, Boat TE, Spock A, Gorvoy JD, Quittel L, Friedman KJ, Silverman LM and et al. A novel mutation in the cystic fibrosis gene in patients with pulmonary disease but normal sweat chloride concentrations. N Engl J Med 1994; 331: 974-980.
14. Dork T, Wulbrand U and Tummler B. Four novel cystic fibrosis mutations in splice junction sequences affecting the CFTR nucleotide binding folds. Genomics 1993; 15: 688-691.
15. Ramalho AS, Beck S, Penque D, Gonska T, Seydewitz HH, Mall M and Amaral MD. Transcript analysis of the cystic fibrosis splicing mutation 1525-1G>A shows use of multiple alternative splicing sites and suggests a putative role of exonic splicing enhancers. J Med Genet 2003; 40: e88.
16. Fairbrother WG, Yeh RF, Sharp PA and Burge CB. Predictive identification of exonic splicing enhancers in human genes. Science 2002; 297: 1007-1013.
17. Maimaiti M, Takahashi S, Okajima K, Suzuki N, Ohinata J, Araki A, Tanaka H, Mukai T and Fujieda K. Silent exonic mutation in the acid-alpha-glycosidase gene that causes glycogen storage disease type II by affecting mRNA splicing. J Hum Genet 2009; 54: 493-496.
18. Zampieri S, Buratti E, Dominissini S, Montalvo AL, Pittis MG, Bembi B and Dardis A. Splicing mutations in glycogen-storage disease type II: evaluation of the full spectrum of mutations and their relation to patients' phenotypes. Eur J Hum Genet 2011; 19: 422-431.
19. Montalvo AL, Bembi B, Donnarumma M, Filocamo M, Parenti G, Rossi M, Merlini L, Buratti E, De Filippi P, Dardis A, Stroppiano M, Ciana G and Pittis MG. Mutation profile of the GAA gene in 40 Italian patients with late onset glycogen storage disease type II. Hum Mutat 2006; 27: 999-1006.
20. Raben N, Lee E, Lee L, Hirschhorn R and Plotz PH. Novel mutations in African American patients with glycogen storage disease Type II. Mutations in brief no. 209. Online. Hum Mutat 1999; 13: 83-84.
21. Loo JC, Liu L, Hao A, Gao L, Agatep R, Shennan M, Summers A, Goldstein AM, Tucker MA, Deters C, Fusaro R, Blazer K, Weitzel J, Lassam N, Lynch H and Hogg D. Germline splicing mutations of CDKN2A predispose to melanoma. Oncogene 2003; 22: 6387-6394.
22. Resta N, Stella A, Susca FC, Di Giacomo M, Forleo G, Miccolis I, Rossini FP, Genuardi M, Piepoli A, Grammatico P and Guanti G. Two novel mutations and a new STK11/LKB1 gene isoform in Peutz-Jeghers patients. Hum Mutat 2002; 20: 78-79.
23. Hastings ML, Resta N, Traum D, Stella A, Guanti G and Krainer AR. An LKB1 AT-AC intron mutation causes Peutz-Jeghers syndrome via splicing at noncanonical cryptic splice sites. Nat Struct Mol Biol 2005; 12: 54-59.
24. Nijbroek G, Sood S, McIntosh I, Francomano CA, Bull E, Pereira L, Ramirez F, Pyeritz RE and Dietz HC. Fifteen novel FBN1 mutations causing Marfan syndrome detected by heteroduplex analysis of genomic amplicons. Am J Hum Genet 1995; 57: 8-21.
25. Wang M, Price C, Han J, Cisler J, Imaizumi K, Van Thienen MN, DePaepe A and Godfrey M. Recurrent mis-splicing of fibrillin exon 32 in two patients with neonatal Marfan syndrome. Hum Mol Genet 1995; 4: 607-613.
26. Maslen C, Babcock D, Raghunath M and Steinmann B. A rare branch-point mutation is associated with missplicing of fibrillin-2 in a large family with congenital contractural arachnodactyly. Am J Hum Genet 1997; 60: 1389-1398.
27. Burrows NP, Nicholls AC, Richards AJ, Luccarini C, Harrison JB, Yates JR and Pope FM. A point mutation in an intronic branch site results in aberrant splicing of COL5A1 and in Ehlers-Danlos syndrome type II in two British families. Am J Hum Genet 1998; 63: 390-398.
28. Kuivenhoven JA, Weibusch H, Pritchard PH, Funke H, Benne R, Assmann G and Kastelein JJ. An intronic mutation in a lariat branchpoint sequence is a direct cause of an inherited human disorder (fish-eye disease). J Clin Invest 1996; 98: 358-364.
29. Li M, Kuivenhoven JA, Ayyobi AF and Pritchard PH. T→G or T→A mutation introduced in theof lecithin:cholesterol acyltransferase (LCAT) gene: intron retention causing LCAT deficiency. Biochim Biophys Acta 1998; 1391: 256-264.
30. Li M and Pritchard PH. Characterization of the effects of mutations in the putative branchpoint sequence of intron 4 on the splicing
31. Di Leo E, Panico F, Tarugi P, Battisti C, Federico A and Calandra S. A point mutation in the lariat branch point of intron 6 of NPC1 as the cause of abnormal pre-mRNA splicing in Niemann-Pick type C disease. Hum Mutat 2004; 24: 440.
32. Crotti L, Lewandowska MA, Schwartz PJ, Insolia R, Pedrazzini M, Bussani E, Dagradi F, George AL Jr and Pagani F. A KCNH2 branch point mutation causing aberrant splicing contributes to an explanation of genotype-negative long QT syndrome. Heart Rhythm 2009; 6: 212-218.
33. Bishop DF, Schneider-Yin X, Clavero S, Yoo HW, Minder EI and Desnick RJ. Congenital erythropoietic porphyria: a novel uroporphyrinogen III synthase branchpoint mutation reveals underlying wild-type alternatively spliced transcripts. Blood 2010; 115: 1062-1069.
34. Aten E, Sun Y, Almomani R, Santen GW, Messemaker T, Maas SM, Breuning MH and den Dunnen JT. Exome sequencing identifies a branch point variant in Aarskog-Scott syndrome. Hum Mutat 2013; 34: 430-434.
35. Montejo JM, Magallon M, Tizzano E and Solera J. Identification of twenty-one new mutations in the factor IX gene by SSCP analysis. Hum Mutat 1999; 13: 160-165.
36. Fernandez Alanis E, Pinotti M, Dal Mas A, Balestra D, Cavallari N, Rogalska ME, Bernardi F and Pagani F. An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects. Hum Mol Genet 2012; 21: 2389-2398.
37. Carboni N, Floris M, Mateddu A, Porcu M, Marrosu G, Solla E, Cocco E, Mura M, Marini S, Maioli MA, Piras R, Aste R and Marrosu MG. Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5. Muscle Nerve 2011; 43: 688-693.
38. Hefferon TW, Groman JD, Yurk CE and Cutting GR. A variable dinucleotide repeat in the CFTR gene contributes to phenotype diversity by forming RNA secondary structures that alter splicing. Proc Natl Acad Sci U S A 2004; 101: 3504-3509